The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.40

Today's change-0.01 -0.71%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.40

Today's change-0.01 -0.71%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc down (U.S.)$0.01

Infinity Pharmaceuticals Inc closed lower Friday, dropping (U.S.)$0.01 or 0.71% to (U.S.)$1.40. Over the last five days, shares have gained 1.45% and 3.70% year to date. Shares have underperformed the S&P 500 by 26.70% during the last year.

Key company metrics

  • Open(U.S.) $1.41
  • Previous close(U.S.) $1.41
  • High(U.S.) $1.45
  • Low(U.S.) $1.37
  • Bid / Ask(U.S.) $1.31 / (U.S.) $2.24
  • YTD % change+3.70%
  • Volume409,336
  • Average volume (10-day)389,237
  • Average volume (1-month)562,977
  • Average volume (3-month)682,623
  • 52-week range(U.S.) $0.84 to (U.S.) $3.84
  • Beta2.59
  • Trailing P/E107.28×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.01
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.53%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue0009
Total other revenue--------
Total revenue0009
Gross profit--------
Total cost of revenue--------
Total operating expense102320-44
Selling / general / administrative69716
Research & development4151353
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-10-23-2053
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-10-23-1953
Income after tax-10-23-1953
Income tax, total--00--
Net income-10-23-1953
Total adjustments to net income--------
Net income before extra. items-10-23-1953
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-23-1953
Inc. avail. to common incl. extra. items-10-23-1953
Diluted net income-10-23-1953
Dilution adjustment------0
Diluted weighted average shares50505049
Diluted EPS excluding extraordinary itemsvalue per share-0.21-0.46-0.391.07
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.21-0.46-0.391.07